United States Biosimilar Market to Grow at 19.3% C..

Yeni bir makale oluşturdu

1 gün

United States Biosimilar Market to Grow at 19.3% CAGR by 2032| IMARC Group | #healthcare

United States Biosimilar Market to Grow at 19.3% CAGR by 2032| IMARC Group

United States Biosimilar Market to Grow at 19.3% CAGR by 2032| IMARC Group

The United States biosimilar market is witnessing rapid growth as more biosimilar drugs gain FDA approval, expanding treatment options for patients.

Beğen

Yorum yap

Paylaş